Sickle Cell Disease Registry Study in Central Europe

This is a registry study — meaning researchers are collecting and organizing medical information from people with sickle cell disease across three countries in central Europe. The goal is to understand how the disease affects different people, what treatments work best, and what can predict how the disease will progress over time. By gathering this information from many patients in one place, doctors hope to find patterns that will help them care for future patients better.

Sickle cell disease is serious, but many of its worst complications can be prevented if caught early and treated the right way. Right now, there isn't enough organized data about how sickle cell disease affects people in Germany, Austria, and Switzerland. This study aims to create that data so doctors can update treatment guidelines and decide whether sickle cell disease should be screened for in all newborns.